In addition to elevated IL-17 levels, an increased concentration of CCL20 was also detected in the synovial fluid of RA patients, and in vitro cultured synovial fibroblasts of RA patients were capable of producing CCL20 after treating them with IL-1 and TNFα [12, 13]. This evidence concerns the gene CCL20 and rheumatoid arthritis.